UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 93 filers reported holding UROGEN PHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,296,089 | +12.0% | 125,226 | 0.0% | 0.01% | +66.7% |
| Q1 2023 | $1,157,088 | +4.2% | 125,226 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $1,110,755 | +6.6% | 125,226 | 0.0% | 0.01% | -46.2% |
| Q3 2022 | $1,042,000 | +1.6% | 125,226 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $1,026,000 | -8.1% | 125,226 | -2.4% | 0.01% | -35.3% |
| Q1 2022 | $1,117,000 | -8.4% | 128,255 | 0.0% | 0.02% | -10.5% |
| Q4 2021 | $1,220,000 | +621.9% | 128,255 | +1177.3% | 0.02% | +375.0% |
| Q3 2021 | $169,000 | +10.5% | 10,041 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $153,000 | -21.9% | 10,041 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $196,000 | – | 10,041 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |